Pfizer Inc.

NYSE:PFE   3:59:58 PM EDT
52.32
-0.11 (-0.21%)
Earnings Announcements

Cansino Biologics Terminates Marketing Cooperation With Pfizer Over MCV4 Vaccine Product

Published: 06/05/2022 08:59 GMT
Pfizer Inc. (PFE) - Says It Terminates Cooperation With Pfizer Regarding Marketing and Promotion of Mcv4 Vaccine Product.
Says It Has Not Generated Sales Revenue Related to Mcv4 Vaccine Product As of Date.
Says It Expects the Termination Will Not Have Significant Adverse Impact on Co's Financial Results.
Revenue is expected to be $25.45 Billion
Adjusted EPS is expected to be $1.79

Next Quarter Revenue Guidance is expected to be $25.7 Billion
Next Quarter EPS Guidance is expected to be $1.89

More details on our Analysts Page.